The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,298.00
Bid: 9,296.00
Ask: 9,300.00
Change: 94.00 (1.02%)
Spread: 4.00 (0.043%)
Open: 9,226.00
High: 9,298.00
Low: 9,214.00
Prev. Close: 9,204.00
NXT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

3 Aug 2023 07:00

RNS Number : 1350I
Next PLC
03 August 2023
 

Second Quarter Trading Statement - 3 August 2023

HEADLINES

Full price sales1 in the second quarter (May-July) were up +6.9% on last year.

On 19 June we issued an unscheduled Trading Statement after a period of much better than expected full price sales, mainly driven by exceptionally warm weather. Since then, full price sales have been up +3.7% on last year. This was ahead of our guidance of +0.5%.

The end-of-season Sale has gone well and clearance rates were ahead of our expectations.

We are increasing our full year guidance for Group profit before tax by £10m to £845m.

1. Full price sales are VAT exclusive sales (including the full value of commission based sales), less items sold in Sale events and Clearance. They also exclude Joules sales and sales through Total Platform. Full price sales are not statutory sales.

FULL PRICE SALES PERFORMANCE

Full price sales performance versus last year, by business division, is set out below for the second quarter and the first half. For completeness, performance reported in the unscheduled Trading Statement is shown in grey along with the last six weeks.

Full price sales by division

versus last year

Q2: 7 weeks

to 17 June

Q2: 6 weeks

to 29 July

Q2: 13 weeks

to 29 July

H1: 26 weeks

to 29 July

Online

+13.7%

+5.0%

+10.0%

+4.1%

Retail

+3.1%

+1.0%

+2.2%

+0.9%

Total Product full price sales

+9.5%

+3.4%

+6.9%

+2.9%

Finance interest income

+6.5%

+7.4%

+6.9%

+7.1%

Total full price sales inc. interest income

+9.3%

+3.7%

+6.9%

+3.2%

END-OF-SEASON SALE

Stock levels have been well controlled and we went into the end-of-season Sale with surplus stock down -22% versus last year. Clearance rates, to date, are ahead of last year and ahead of our internal forecasts, which has added around £4m to Group profit before tax.

GUIDANCE FOR FULL PRICE SALES, PROFIT AND EARNINGS PER SHARE

Full price sales guidance

We are maintaining our forecast for full price sales to be up +0.5% versus last year in the second half, which implies full price sales for the full year will be up +1.8%. 

Revised profit and EPS full year guidance

The combination of:

£16m of additional full price sales in the last six weeks and

improved clearance rates in our end-of-season summer Sale

mean that we expect to generate £10m more profit than we anticipated in our last Trading Statement. Accordingly, we are raising our guidance to £845m. The table below sets out our new guidance for the full year, along with the previous guidance.

Full year guidance

Latest guidance

Versus

last year

Previous guidance2

Versus

last year

Full price sales

£4.68bn

+1.8%

£4.67bn

+1.4%

NEXT Profit before tax

£845m

- 2.9%

£835m

- 4.1%

Pre-tax EPS

700.1p

- 0.2%

692.0p

- 1.3%

Post-tax EPS

535.3p

- 6.6%

529.2p

- 7.7%

2. Please note that EPS guidance was not provided in June's Unscheduled Trading Statement. The EPS forecast at that time is shown here for completeness.

INTERIM RESULTS

We are scheduled to announce our results for the first half of the year on Thursday 21 September 2023. 

 

Forward Looking Statements

Certain statements in this Trading Update are forward looking statements. These statements may contain the words "anticipate", "believe", "intend", "aim", "expects", "will", or words of similar meaning. By their nature, forward looking statements involve risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. As such, undue reliance should not be placed on forward looking statements. Except as required by applicable law or regulation, NEXT plc disclaims any obligation or undertaking to update these statements to reflect events occurring after the date these statements were published.

 

 

Date:

Embargoed until 07:00 hrs, Thursday 3 August 2023

Contacts:

Amanda James, Group Finance Director (analyst calls)Alistair Mackinnon-Musson, Rowbell PR

Tel: 0333 777 8888Tel: 020 7717 5239

Photographs:

https://www.nextplc.co.uk/media/image-gallery/campaign-images

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVLLFBXVLZBBE
Date   Source Headline
1st Jun 20209:47 amRNSTotal Voting Rights
14th May 202012:30 pmRNSResult of AGM
1st May 20209:01 amRNSTotal Voting Rights
29th Apr 20207:00 amRNSTrading Statement
27th Apr 202010:55 amRNSDisclosure of Rights Attaching to Equity Shares
14th Apr 20204:40 pmRNSAnnual Financial Report
14th Apr 20207:00 amRNSNEXT Reopens Online, Warehousing and Distribution
8th Apr 20205:10 pmRNSDirector/PDMR Shareholding
3rd Apr 20206:03 pmRNSCovid Corporate Financing Facility (CCFF)
1st Apr 20205:40 pmRNSDirector/PDMR Shareholding
1st Apr 20209:06 amRNSTotal Voting Rights
27th Mar 20209:34 amRNSHolding(s) in Company
27th Mar 20207:00 amRNSNEXT PLC - UPDATE ON OPERATIONS
24th Mar 20205:41 pmRNSDirector/PDMR Shareholding
23rd Mar 20204:42 pmRNSDirector/PDMR Shareholding
23rd Mar 20201:12 pmRNSHolding(s) in Company
20th Mar 20205:09 pmRNSDirector/PDMR Shareholding
19th Mar 20207:00 amRNSResults for the Year Ending January 2020
2nd Mar 202010:16 amRNSTotal Voting Rights
13th Feb 20205:32 pmRNSTransaction in Own Shares
12th Feb 20205:13 pmRNSTransaction in Own Shares
11th Feb 20205:07 pmRNSTransaction in Own Shares
10th Feb 20205:32 pmRNSTransaction in Own Shares
7th Feb 20205:32 pmRNSTransaction in Own Shares
6th Feb 20206:10 pmRNSTransaction in Own Shares
3rd Feb 202010:13 amRNSTotal Voting Rights
24th Jan 202010:05 amRNSBlock Listing Interim Review and Cancellation
3rd Jan 20204:21 pmRNSHolding(s) in Company
3rd Jan 20207:00 amRNSTrading Statement
31st Dec 20191:30 pmRNSTotal Voting Rights
30th Dec 20194:01 pmRNSSir David Jones CBE
2nd Dec 20192:00 pmRNSTotal Voting Rights
31st Oct 20195:00 pmRNSTotal Voting Rights
30th Oct 20197:00 amRNSNEXT PLC - Trading Statement
15th Oct 20194:24 pmRNSDirector/PDMR Shareholding
1st Oct 20199:21 amRNSTotal Voting Rights
23rd Sep 20196:18 pmRNSDirector/PDMR Shareholding
20th Sep 20195:00 pmRNSDirector/PDMR Shareholding
19th Sep 20197:00 amRNSResults for the Half Year Ending July 2019
30th Aug 20193:35 pmRNSTotal Voting Rights
8th Aug 20195:06 pmRNSTransaction in Own Shares
7th Aug 20195:40 pmRNSTransaction in Own Shares
6th Aug 20196:05 pmRNSTransaction in Own Shares
5th Aug 20195:33 pmRNSTransaction in Own Shares
31st Jul 20195:48 pmRNSDirector/PDMR Shareholding
31st Jul 20194:26 pmRNSTotal Voting Rights
31st Jul 20197:00 amRNSTrading Statement
25th Jul 201910:43 amRNSBlock listing Interim Review
15th Jul 20193:20 pmRNSHolding(s) in Company
28th Jun 20194:55 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.